New Assessment Tool Helps Hospitals Evaluate, Improve Antibiotic Use

New Assessment Tool Helps Hospitals Evaluate, Improve Antibiotic Use

As part of an ongoing collaboration to improve stewardship of lifesaving antibiotics in the U.S., Pew and the Centers for Disease Control and Prevention (CDC) developed a new resource to help hospitals reduce the risk of antibiotic resistance and improve patient care. Created with input from leading antibiotic use experts, the standardized antibiotic administration ratio (SAAR) assessment tool will help health care providers interpret and use antibiotic prescribing data from the CDC’s National Healthcare Safety Network. Pew and CDC hope that hospitals will use this resource to evaluate the appropriateness of their antibiotic use and for targeting stewardship initiatives moving forward.

See the assessment guide here.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.